Janaki Manoja Vinnakota

6PUBLICATIONS
92CO-AUTHORS
Tumour immunologyMedical infection agents (incl. prions)Innate immunityMolecular targetsApplied immunology (incl. antibody engineering, xenotransplantation and t-cell therapies)
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (6)

|Sep 30, 2026
Spatial Transcriptomics Reveals a T Cell-Mediated Microglial Activation Axis of Immune Checkpoint Inhibition-Related Adverse Events in the Brain.

|Jul 08, 2025
Gut microbiota-derived TMAVA is a modulator of acute CNS-GVHD.

Sangya Chatterjee, Tamina Rückert, Ina Martin

|Mar 31, 2025
AhR activation mitigates graft-versus-host disease of the central nervous system by reducing microglial NF-κB signaling.

Alexander Zähringer, Inês Morgado, Daniel Erny

|Jun 17, 2024
Oncogenic Calreticulin Induces Immune Escape by Stimulating TGFβ Expression and Regulatory T-cell Expansion in the Bone Marrow Microenvironment.

Dominik Schmidt, Cornelia Endres, Rouven Hoefflin

|Jun 12, 2024
Anti-PD-1 cancer immunotherapy induces central nervous system immune-related adverse events by microglia activation.

Janaki Manoja Vinnakota, Rachael C Adams, Dimitrios Athanassopoulos

|Dec 04, 2023
CSF1R inhibition promotes neuroinflammation and behavioral deficits during graft-versus-host disease in mice.

Rachael C Adams, Dylan Carter-Cusack, Genesis T Llanes

Pageof 1

Frequent Collaborators

5 joint publications

Robert Zeiser

4 joint publications

Geoffroy Andrieux

4 joint publications

Alexander Zähringer

3 joint publications

Rachael C Adams